Metabolomics Market Worth $3,301 Million by 2023 | Key Segments, Benefits & Opportunity

The rise in global incidences of chronic diseases and increasing demand for personalized medicine propel the growth of the global metabolomics market.

PORTLAND, OREGON, UNITED STATES, October 21, 2021 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/525

The growth of the global metabolomics market is driven by rise in prevalence of chronic diseases worldwide, an upsurge in R&D investment for the development of metabolomics, and an increase in demand for personalized medicine. However, the lack of skilled professionals in the field along with the astronomical price of metabolomic instruments hampers market growth. Nonetheless, the immense potential of metabolomics in disease diagnostics and its growing prospect in human nutrition would create lucrative opportunities for emerging market players in the near future.

Metabolomics is an innovative approach for the treatment and diagnosis of chronic diseases. Increased adoption of metabolomics in drug development and personalized healthcare is expected to fuel the market growth during the forecast period.

The global metabolomics market is expected to grow at a lucrative rate during the forecast period due to increased adoption of metabolomics in precision medicine and surge in R&D investments. Moreover, technological advancements in auxiliary medical devices used for metabolomics analysis and growth in demand for the development of quality medications are expected to fuel the metabolomics market. However, high cost of medical devices and lack of effective data management for metabolomic profiling hamper the market growth.

Comprehensive competitive analysis and profiles of major market players, such as

Agilent Technologies, Inc.
Danaher Corporation
Biocrates Life Sciences AG
Bruker Corporation
Leco Corporation
Metabolon, Inc.
Human Metabolome Technologies, Inc.
Bio-Rad Laboratories, Inc.
Shimadzu Corporation
Waters Corporation
Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Metabolomics Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Metabolomics Market analysis from 2020 to 2023, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Metabolomics Market growth.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS.....................................................................

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Lab-on-Chip Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Lab-on-Chip Market in 2020?
Q4. Which is base year calculated in the Lab-on-Chip Market report?
Q5. Does the Lab-on-Chip Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Lab-on-Chip Market?
Q7. Does the Lab-on-Chip Market report provides Value Chain Analysis?
Q8. What are the key trends in the Lab-on-Chip Market report?

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/525

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Medical/Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Defibrillators Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn